Genetics / genomes

DNA sequencing
#Genetic diseases #Genetics / genomes #Rare diseases #SynaptixBio #UK #UK government

UK genetic screening plan welcomed by biotech

The UK Government has announced that every newborn baby in England will have their genetic code mapped to test for a wide range of conditions, part of a plan that will also see £650m invested in DNA research by 2030.  The Department for Health and Social Care… Read More

#News

#GeneDx #Genetics / genomes #Genomics #PacBio

New study cracks genomic challenge: Paralogous genes

A newly published study in Nature Communications unveils a powerful new method for analysing some of the most complex regions of the human genome. Led by researchers from PacBio, GeneDx, and a global consortium of genomics experts, the study utilises Paraphase, an informatics tool that, when paired with HiFi long-read… Read More

#News

AI and genomics
#AI / data analytics / healthtech / informatics #DNA #Genetics / genomes #Precision medicine #Rare disease

New podcast on the future for genomics and big data

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “What’s the next step in big… Read More

#News

Mammography
#Breast cancer #Cancer research #European Commission #Gene mutation #Genetics / genomes #HER2 #Oncology

Drug approved for breast cancer with low levels of HER2 expression

Enhertu has been approved in the EU as the first HER2 directed therapy for patients with HER2 low metastatic breast cancer.  The drug is approved as monotherapy for adult patients who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within six… Read More

#Cancer Research #Editor's Choice #News

#Diagnostics #Genetics / genomes #Rare disease

PacBio and Children’s Mercy expand genetic research collaboration 

PacBio has expanded a research collaboration with Children’s Mercy Kansas City in an effort to improve scientists’ understanding of the genetic underpinnings of rare diseases.   The collaboration will see Children’s Mercy Kansas City use the multi-omics capabilities of PacBio’s Sequel IIe system in the study of genetic… Read More

#News

#Ageing #Genetics / genomes #Wellcome Sanger Institute

Researchers shed light on ageing in new study   

Animals with a large difference in lifespan and size end their natural lives with a similar number of genetic changes, researchers have discovered.   The findings come from a study by the Wellcome Sanger Institute which analysed genomes from 16 species of mammal to understand the role genetic… Read More

#News

#Alzheimer's #Genetics / genomes

Scientists uncover new genetic factors for Alzheimer’s disease  

Scientists have discovered 75 genetic risk factors for Alzheimer’s disease in research which could help with the development of new therapies.   An international group of scientists from Inserm, Institut Pasteur de Lille, Lille University Hospital, and Université de Lille and the University of Bristol… Read More

#News

#Corning Life Sciences #Drug delivery #Drug development #Drug discovery #Gene therapy #Genetics #Genetics / genomes #Life sciences #Research

Process Development in Gene Therapy: Four Things to Know

By John Yoshi Shyu, Ph.D. Corning Life Sciences. Gene therapy – the addition, deletion, or modification of genes in living organisms – has been around, at least in concept, since the 1980s. Gene modification or editing incorporates two main strategies: insertion of novel genetic constructs into existing genes, and gene… Read More

#Exclusive Content #News

#Biologics #Covid-19 #Drug delivery #Gene therapy #Genetics / genomes #Immunology / Virology & Vaccines #RNA

The challenge of providing rapid, effective protection against Covid-19

Lisa Osborne, CEO at RANA Healthcare Solutions interviews Daniel Kavanagh, PhD, Senior Scientific Advisor, Gene Therapy at WCG. The Covid-19 pandemic has put vaccine development centre-stage. Never have citizens around the world been so focused on the length of time it takes to develop, test, approve, manufacture and distribute new… Read More

#Covid-19 #Exclusive Content #News

#Cancer research #Drug development #Genetics / genomes #Laboratory data #Research

‘Patchwork’ tumours prevalent across multiple cancer types

Researchers at the Francis Crick Institute, as part of an international collaboration of scientists through the Pan-Cancer Analysis of Whole Genomes Consortium, have analysed the whole genomes of tumour samples from over 2,600 patients with different types of cancer. They identified a high prevalence of genetic diversity within individual tumours,… Read More

#Cancer Research #News

#Biotechnology #Drug discovery #Genetics / genomes #Genetics / genomics #Research

Francis Crick Institute and GSK to pioneer reactive fragment screening

Researchers at the Francis Crick Institute and GSK are extending their collaboration to advance the discovery of new drug targets in a £11.5 million effort. This comes after receiving a ‘Prosperity Partnership’ grant from the Engineering and Physical Sciences Research Council (EPSRC) and matching funds from GSK. Together, the teams… Read More

#News

#Genetics / genomes #Genomics

IDT launches new CRISPR analysis system

IDT, genomics solutions provider, has launched a new system to provide an end-to-end solution for characterising and quantifying the full array of on and off-target genome editing events in CRISPR research projects, and other genome editing projects. The system uses IDT rhAmpSeq technology, which is designed to enable accurate amplicon… Read More

#News

#Genetics / genomes #Genome sequencing

Middle East genome-wide study reveals Arab genetic risk factors

A group of researchers at Qatar Foundation have reported the first and largest genetic association study in the Middle East, that has been published online in Nature Communications. The study titled Whole genome sequencing in the Middle Eastern Qatari population identifies genetic associations with 45 clinically relevant traits highlights a vital… Read More

#Editor's Choice #News

#Academic #AI / data analytics / healthtech / informatics #Animal models #Biomarkers #Business #Cell therapy #Cellular & Molecular biology #Chemical engineering #Chemistry #Clinical specialities #Clinical trials #Combinatorial chemistry #Drug development #Drug discovery #Drug repositioning #Gene therapy #Genetics / genomes #High Content Screening #High throughput screening #Immunology #Immunology / Virology & Vaccines #Lead discovery #Molecular medicine #PCR #RNA #Screening #Stem cells #System biology #Systems biology #Therapeutics #Translational #Translational chemistry

Race To COVID-19 cure – the Core Model for solving the pandemic crisis (Part 1 & 2)

By Ibis Sanchez-Serrano and Rathnam Chaguturu Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes this disease. This article examines the major initiatives being explored at the public policy level to… Read More

#Covid-19 #Exclusive Content